Home India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
 

Keywords :   


India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug

2013-03-18 16:20:28| Biotech - Topix.net

India's BDR Pharmaceuticals International Pvt Ltd has applied to the Indian patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, dasatinib, through a so-called compulsory licence mechanism, a BDR executive said on Monday.

Tags: version sell drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 15
07.11Hurricane Rafael Wind Speed Probabilities Number 15
07.11Hurricane Rafael Public Advisory Number 15
07.11Hurricane Rafael Forecast Advisory Number 15
07.11Tropical Depression Fourteen-E Public Advisory Number 4
07.11Summary for Tropical Depression Fourteen-E (EP4/EP142024)
07.11Tropical Depression Fourteen-E Graphics
More »